- Home
- IMNN vs INLF Comparison
IMNN vs INLF Comparison
Compare IMNN & INLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- INLF
- Stock Information
- Founded
- IMNN 1982
- INLF 2016
- Country
- IMNN United States
- INLF China
- Employees
- IMNN N/A
- INLF N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- INLF Industrial Machinery/Components
- Sector
- IMNN Health Care
- INLF Industrials
- Exchange
- IMNN Nasdaq
- INLF Nasdaq
- Market Cap
- IMNN 12.9M
- INLF 13.3M
- IPO Year
- IMNN 1985
- INLF 2025
- Fundamental
- Price
- IMNN $5.33
- INLF $0.72
- Analyst Decision
- IMNN Buy
- INLF
- Analyst Count
- IMNN 2
- INLF 0
- Target Price
- IMNN $182.61
- INLF N/A
- AVG Volume (30 Days)
- IMNN 153.1K
- INLF 320.0K
- Earning Date
- IMNN 11-06-2025
- INLF 09-29-2025
- Dividend Yield
- IMNN N/A
- INLF N/A
- EPS Growth
- IMNN N/A
- INLF N/A
- EPS
- IMNN N/A
- INLF N/A
- Revenue
- IMNN N/A
- INLF $19,332,282.00
- Revenue This Year
- IMNN N/A
- INLF N/A
- Revenue Next Year
- IMNN N/A
- INLF N/A
- P/E Ratio
- IMNN N/A
- INLF N/A
- Revenue Growth
- IMNN N/A
- INLF 33.11
- 52 Week Low
- IMNN $4.70
- INLF $0.71
- 52 Week High
- IMNN $41.22
- INLF $21.00
- Technical
- Relative Strength Index (RSI)
- IMNN 47.96
- INLF 32.50
- Support Level
- IMNN $5.04
- INLF $0.71
- Resistance Level
- IMNN $5.55
- INLF $0.75
- Average True Range (ATR)
- IMNN 0.29
- INLF 0.03
- MACD
- IMNN 0.04
- INLF 0.00
- Stochastic Oscillator
- IMNN 70.94
- INLF 16.23
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About INLF INLIF LIMITED
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.